OBJECTIVES: Due to limited research on the association between recurrence of mood episodes and the longitudinal course of neurocognitive functioning in early phase bipolar I disorder (BD I), the impact of recurrence on neurocognition remains unclear. Further, a strong correlation between neurocognitive impairment and functional impairment has been demonstrated. The longitudinal relationship between neurocognitive impairment and functional outcome in relation to recurrence is, however, not established. METHODS: The current study investigated the longitudinal relationship between neurocognition, recurrence of mood episodes and functional outcome in a sample of first-treatment (FT) BD I patients (N = 42), with and without relapse, during a 1-year follow-up period. The longitudinal course of neurocognitive functioning in the patients was also compared to that of a group of healthy controls (N = 143). RESULTS: Compared to both patients with relapse and healthy controls, no-relapse patients showed neurocognitive improvements. The polarity of the relapse episodes was mostly depressive, and for the no-relapse patients, reduction of symptoms was associated with neurocognitive improvement. No-relapse patients showed better global and occupational functioning. CONCLUSIONS: The current study found different neurocognitive and functional trajectories in FT BD I patients with and without relapse, with differences at follow-up to some degree being mediated by current symptoms. The current findings highlight the importance of treatment focusing on neurocognition and symptom states with the aim of improving functional recovery.
OBJECTIVES: Due to limited research on the association between recurrence of mood episodes and the longitudinal course of neurocognitive functioning in early phase bipolar I disorder (BD I), the impact of recurrence on neurocognition remains unclear. Further, a strong correlation between neurocognitive impairment and functional impairment has been demonstrated. The longitudinal relationship between neurocognitive impairment and functional outcome in relation to recurrence is, however, not established. METHODS: The current study investigated the longitudinal relationship between neurocognition, recurrence of mood episodes and functional outcome in a sample of first-treatment (FT) BD I patients (N = 42), with and without relapse, during a 1-year follow-up period. The longitudinal course of neurocognitive functioning in the patients was also compared to that of a group of healthy controls (N = 143). RESULTS: Compared to both patients with relapse and healthy controls, no-relapse patients showed neurocognitive improvements. The polarity of the relapse episodes was mostly depressive, and for the no-relapse patients, reduction of symptoms was associated with neurocognitive improvement. No-relapse patients showed better global and occupational functioning. CONCLUSIONS: The current study found different neurocognitive and functional trajectories in FT BD I patients with and without relapse, with differences at follow-up to some degree being mediated by current symptoms. The current findings highlight the importance of treatment focusing on neurocognition and symptom states with the aim of improving functional recovery.
Authors: Katherine E Burdick; Caitlin E Millett; Anastasia K Yocum; Cara M Altimus; Ole A Andreassen; Valerie Aubin; Raoul Belzeaux; Michael Berk; Joanna M Biernacka; Hilary P Blumberg; Anthony J Cleare; Claudia Diaz-Byrd; Caroline Dubertret; Bruno Etain; Lisa T Eyler; Brent P Forester; Janice M Fullerton; Mark A Frye; Sébastien Gard; Ophelia Godin; Emmanuel Haffen; Federica Klaus; Trine Vik Lagerberg; Marion Leboyer; Anabel Martinez-Aran; Susan McElroy; Philip B Mitchell; Emilie Olie; Phebe Olorunfemi; Christine Passerieux; Amy T Peters; Daniel L Pham; Mircea Polosan; Julia R Potter; Martha Sajatovic; Ludovic Samalin; Raymund Schwan; Megan Shanahan; Brisa Solé; Rebecca Strawbridge; Amanda L Stuart; Ivan Torres; Torrill Ueland; Eduard Vieta; Lana J Williams; Anna L Wrobel; Lakshmi N Yatham; Allan H Young; Andrew A Nierenberg; Melvin G McInnis Journal: Bipolar Disord Date: 2022-03-23 Impact factor: 5.345
Authors: Caterina Del Mar Bonnín; María Reinares; Anabel Martínez-Arán; Esther Jiménez; Jose Sánchez-Moreno; Brisa Solé; Laura Montejo; Eduard Vieta Journal: Int J Neuropsychopharmacol Date: 2019-08-01 Impact factor: 5.176
Authors: Bo H Jonsson; Funda Orhan; Sanna Bruno; Ana Osório Oliveira; Timea Sparding; Mikael Landen; Carl M Sellgren Journal: Brain Behav Date: 2021-12-30 Impact factor: 2.708
Authors: Heather A MacPherson; Anastacia Y Kudinova; Elana Schettini; Gracie A Jenkins; Anna C Gilbert; Sarah A Thomas; Kerri L Kim; Petya D Radoeva; Rebecca L Babcock Fenerci; Shirley Yen; Heather Hower; Jeffrey Hunt; Martin B Keller; Daniel P Dickstein Journal: Eur Child Adolesc Psychiatry Date: 2021-01-03 Impact factor: 5.349